|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Predictive power of pretreatment prognostic factors in hepatoblastoma: a report of the Children's Oncology Group 显示文摘 | Meyers RL Rowland JR Krailo M | 2009 | Pediatr Blood Cancer2009，53，6： | 1 |
| 2 | Predictive power of pretreatment prognostic factors in children with hepatoblastoma:a report from the Children's Oncology Group显示文摘 | Meyers RL Rowland JR Krailo M | | 0，，06： | 1 |
| 3 | Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neurosctodermal tumor of bone显示文摘 | Grier HE Krailo MD Tarbell NJ | 2003 | N Engl J Med2003，348，8： | 1 |
| 4 | Treatment of metastatic Ewing' s sarcoma/primitive neuroectodermal tumor of bone: Evaluation of increasing the dose intensity of chemotherapy-a report from the children' s oncology group 显示文摘 | Miser JS Goldsby RE Chen Z Krailo MD Tarbell NJ Link MP | 2007 | Pediatr Blood Cancer2007，49，7： | 1 |
| 5 | Ifosfamide, carboplatin and etoposide in children with poor risk relapsed Wilms' tumor: a Childreffs Cancer Group report显示文摘 | Abu-Ghosh AM Krailo MD Goldman SC | 2002 | Ann Oncol2002，13，： | 1 |
| 6 | Phase 2 trial of sorafenib in children and young adults with refractory solid tumors: a report from the Children's Oncology Group 显示文摘 | Kim A Widemann BC Krailo M | 2015 | Pediatr Blood Cancer2015，62，9： | 1 |
| 7 | Addition of ifosfamide and etoposide to standard chemotherapy for Ewing' s sarcoma and primitive neuroectodermal tumor of bone 显示文摘 | Grier HE Krailo MD Tarbell NJ Link MP Fryer CJ Pritchard DJ | 2003 | N Engl J Meal2003，348，8： | 1 |
| 8 | Hepatocellular carcinoma in children and adolescents:results from the pediatric oncology group and the children's cancer group intergroup study显示文摘 | Katzenstein HM Krailo MD Malogolowkin MH | 2002 | J Clin Oncol2002，20，12： | 1 |
| 9 | Phase Ⅱ trial of ixabepilone administered daily for five days in children and young adults with refractory solid tumors:a report from the children's oncology group显示文摘 | Jacobs S Fox E Krailo M | 2010 | Clin Cancer Res2010，16，2： | 1 |
| 10 | A randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing's sarcoma: a report from the Children's Oncology Group显示文摘 | Womer RB West DC Krailo MD | 2012 | J Clin Oncol2012，30，33： | 1 |
| 11 | The combination of ifosfamide(IFOS),etoposide(VP16),and mesna:a very active regimen inthe treatment of recurrent Wilms’tumor(WT)显示文摘 | Miser J Krailo M Hammond GD | 1993 | Proc Am Soc Clin Oncol1993，12，： | 1 |
| 12 | Local Control in Pelvic Ewing Sar-coma:Analysis from INT-0091-a Report from the Children's Oncology Group 显示文摘 | Yock TI Krailo M Fryer CJ | 2006 | Clin Oncol2006，24，24： | 1 |
| 13 | Imatinib mesylate (STI571) for treatment of children with Philadelphia chromosome-positive leukemia: results from a Childreng Oncology Group phase 1 study显示文摘 | Champagne MA Capdeville R Krailo M | 2004 | Blood2004，104，9： | 1 |
| 14 | Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcomaand primitive neuroectodermal tumor of bone显示文摘 | Grier HE Krailo MD Tarbell N J | 2003 | N Engl J Med2003，348，8： | 1 |
| 15 | Out- come for adolescent and young adult patients with osteosarcoma:a report from the children、oncology group显示文摘 | JANEWAY K A BARKAUSKAS D A KRAILO MD | 2012 | Cancer2012，118，18： | 1 |
| 16 | High-dose melphalan, etoposide, total-body irradiation and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis显示文摘 | Meyers PA Krailo MD Ladanyi M | 2001 | J Clin Oncol2001，19，11： | 1 |
| 17 | Ifosfamide,carboplatin and etoposide in children with poor-risk relapsed Wilms’tumor:a Children’s Cancer Group report显示文摘 | Abu-Ghosh AM Krailo MD Goldman SC | 2002 | Annals of Oncology2002，13，3： | 1 |
| 18 | , Osteosarcoma: The addition of muramyl tripeptide to chemotherapy improves overall survival--A report from the Children' s Oncology Group显示文摘 | Meeyers PA Schwartz CL Krailo MD | 2008 | Journal of Clinical Oncology2008，26，4： | 1 |
| 19 | A phase I clinical, pharma- cological, and biological trial of interleukin-6 plus granulocytecilony stimulating factor after Ifosfamide, Caboplatin, and Etoposide in children with recurrent/refractory solid tumors enhanced hematological response but a high incidence of grade III/VI constitution- al toxicities 显示文摘 | Bracho F Krailo MD ShenV | 2001 | Clin Cancer Res2001，7，1： | 1 |
| 20 | Surgical resection of pumonary metastatic leisions in children with hepatoblastoma显示文摘 | Meyers RL Katzenstein HM Krailo M | | 0，，12： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员